Format

Send to

Choose Destination
Am J Kidney Dis. 2009 Feb;53(2):192-6. doi: 10.1053/j.ajkd.2008.11.016.

Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD?

Author information

1
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. bernsj@uphs.upenn.edu
PMID:
19166798
DOI:
10.1053/j.ajkd.2008.11.016

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center